Market Research Logo

Puerto Rico Pharmaceuticals & Healthcare Q4 2018

Puerto Rico Pharmaceuticals & Healthcare Q4 2018

Key View:

Puerto Rico’s pharmaceutical and healthcare expenditure will grow at a modest rate over the next five years.The healthcare budget will restrict growth as cost measures targeting drug spending rise and the US administration maintainsa stringent stance towards securing federal healthcare funds for Puerto Rico. Economic challenges and outward migration of labourwill further raise risks to the island's attractiveness to manufacturers, including pharmaceutical producers. However, over our ten-year forecast period, internal devaluation is likely to drive labour and operational costs down, strengthening theisland's competitiveness and therefore its longstanding attractiveness as a manufacturing base.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
Puerto Rico Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
AbbVie
Eli Lilly
GlaxoSmithKline
Merck & Co
Novartis
Sanofi
Puerto Rico Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report